EXPRESS SCRIPTS HOLDING CO. overview

CONCORD, MA / ACCESSWIRE / November 14, 2023 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced that effective November 10 th , Express Scripts has added the iLet Bionic Pancreas and associated monthly supplies to their commercial national formulary offerings. For plans that cover the iLet Bionic Pancreas under their pharmacy benefit and use one of these formularies, this decision makes it faster and easier for eligible users to gain...

Express Scripts Introduces New Option To Give Clients Maximum Simplicity in Drug Pricing PR Newswire ST. LOUIS, Nov. 14, 2023 Express Scripts ClearNetwork SM offers employers and health plans a new option for simple, "cost-plus" pharmacy pricing for brand, generic, and specialty medications. ST. LOUIS , Nov. 14, 2023 /PRNewswire/ -- Express Scripts, the pharmacy benefits management (PBM) business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced a new pharmacy network...

Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients PR Newswire ST. LOUIS, July 10, 2023 Express Scripts will include Cyltezo and both Sandoz products (Hyrimoz and unbranded adalimumab-adaz) – inflammatory disease biosimilars with competitive net costs – as preferred products on the National Preferred Formulary alongside HUMIRA Both the Cyltezo and Sandoz additions offer clinically effective and cost-effective...

Express Scripts® Further Advances Transparency and Affordability for Consumers and Clients PR Newswire ST. LOUIS, April 13, 2023 New Copay Assurance ™ plan (CAP) ensures consumers pay less out-of-pocket by capping copays on prescription drugs: no more than $5 for generics, $25 for preferred brand drugs, and $45 for preferred specialty brand drugs. Introduction of a fully transparent pricing model, ClearCareRx ™ , a simpler option in which employers, health plans, and government employer...

Evernorth Names Adam Kautzner President, Express Scripts PR Newswire BLOOMFIELD, Conn., Jan. 18, 2023 BLOOMFIELD, Conn. , Jan. 18, 2023 /PRNewswire/ -- Evernorth, the health services business of Cigna Corporation (NYSE: CI), today announced the promotion of Adam Kautzner , PharmD, to president, Express Scripts. "Adam's deep expertise in all areas of pharmacy benefit management, including pharma relations, formulary development and value-based pharmacy network contracting, will drive us forward...

Viatris' First-Ever Interchangeable Insulin Biosimilar Preferred on Express Scripts' Largest Formulary Upcoming launch of two interchangeable biosimilar insulin glargine injection options co-developed with Biocon Biologics will help increase access to critical treatment for millions of Americans living with diabetes PR Newswire PITTSBURGH, Oct. 20, 2021 PITTSBURGH , Oct. 20, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) is proud to confirm that Express Scripts, a leading pharmacy benefit...

Express Scripts Awarded 7-Year TRICARE Pharmacy Program Contract - New contract gives Express Scripts the honor of serving TRICARE beneficiaries through 2029 PR Newswire BLOOMFIELD, Conn., Aug. 6, 2021 BLOOMFIELD, Conn. , Aug. 6, 2021 /PRNewswire/ -- The U.S. Department of Defense today awarded Express Scripts, an Evernorth company, a contract for the administration of the TRICARE Pharmacy Program, Fifth Generation. Under the new contract, Express Scripts will serve 9.6 million active-duty...

Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that Express Scripts, one of the leading pharmacy benefit managers (PBM) in the United States, has added EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% to its National Preferred, Basic and High Performance Formularies, effective February 5, 2021. EYSUVIS is the first and only prescription...